TC BioPharm (Holdings) plc stock is down -15.53% since 30 days ago. The next earnings date is Dec 15, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 December’s closed higher than November.
TC Biopharm (Holdings) Plc focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia.